Berobenatide
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
Pfizer · Phase 3 · Recruiting · Enrollment 300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Berobenatide Medium Maintenance Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo Matched to Low-Dose Berobenatide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Berobenatide Low Maintenance Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| Berobenatide High Maintenance Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo Matched to Medium-Dose Berobenatide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo Matched to High-Dose Berobenatide | Obesity or overweight | n/r | n/r | n/r | n/r |